B cells are not essential for lactobacillus-mediated protection against lethal pneumovirus infection

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5265-5272

  Percopo, Caroline M ^a   Dyer, Kimberly D ^a   Garcia Crespo, Katia E ^a,d   Gabryszewski, Stanislaw J ^a,e   Shaffer III, Arthur L ^b   Domachowske, Joseph B ^c   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d AAAS   (United States)

^e Medical Scientist Training Program Columbia University College of Physi and Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GERMINAL CENTER; HETEROLOGOUS IMMUNITY; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LUNG INFILTRATE; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PNEUMOVIRINAE; PNEUMOVIRUS INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; CYTOKINES; LACTOBACILLUS; LUNG; MICE; MICE, INBRED BALB C; PNEUMOVIRUS; PNEUMOVIRUS INFECTIONS; RESPIRATORY MUCOSA;

EID: 84901287783     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400087     Document Type: Article

References (40)

1. Rosenberg, H. F., and J. B. Domachowske. 2012. Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory therapeutics. Curr. Med. Chem. 19: 1424-1431.
2. Rosenberg, H. F., and J. B. Domachowske. 2008. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol. Lett. 118: 6-12.
3. Bem, R. A., J. B. Domachowske, and H. F. Rosenberg. 2011. Animal models of respiratory syncytial virus disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 301: L148-L156.
4. Gabryszewski, S. J., O. Bachar, K. D. Dyer, C. M. Percopo, K. E. Killoran, J. B. Domachowske, and H. F. Rosenberg. 2011. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J. Immunol. 186: 1151-1161.
5. Garcia-Crespo, K. E., C. C. Chan, S. J. Gabryszewski, C. M. Percopo, P. Rigaux, K. D. Dyer, J. B. Domachowske, and H. F. Rosenberg. 2013. Lactobacillus priming of the respiratory tract: heterologous immunity and protection against lethal pneumovirus infection. Antiviral Res. 97: 270-279.
6. Levy, O., and M. G. Netea. 2014. Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines. Pediatr. Res. 75: 184-188.
7. Netea, M. G., J. Quintin, and J. W. M. van der Meer. 2011. Trained immunity: a memory for innate host defense. Cell Host Microbe 9: 355-361.
8. Didierlaurent, A., J. Goulding, and T. Hussell. 2007. The impact of successive infections on the lung microenvironment. Immunology 122: 457-465.
9. Locati, M., A. Mantovani, and A. Sica. 2013. Macrophage activation and polarization as an adaptive component of innate immunity. Adv. Immunol. 120: 163-184.
10. Garly, M. L., C. L. Martins, C. Bale, M. A. Balde, K. L. Hedegaard, P. Gustafson, I. M. Lisse, H. C. Whittle, and P. Aaby. 2003. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 21: 2782-2790.
11. McCullers, J. A. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19: 571-582.
12. Wiley, J. A., L. E. Richert, S. D. Swain, A. Harmsen, D. L. Barnard, T. D. Randall, M. Jutila, T. Douglas, C. Broomell, M. Young, and A. Harmsen. 2009. Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS ONE 4: e7142.
13. Richert, L. E., A. E. Servid, A. L. Harmsen, A. Rynda-Apple, S. Han, J. A. Wiley, T. Douglas, and A. G. Harmsen. 2012. A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine 30: 3653-3665.
14. Randall, T. D. 2010. Bronchus-associated lymphoid tissue (BALT): structure and function. Adv. Immunol. 107: 187-241.
15. Bienenstock, J., and M. R. McDermott. 2005. Bronchus and nasal-associated lymphoid tissues. Immunol. Rev. 206: 22-31.
16. Foo, S. Y., and S. Phipps. 2010. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol. 3: 537-544.
17. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934.
18. Ehrenstein, M. R., and C. A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
19. Moseman, E. A., M. Iannacone, L. Bosurgi, E. Tonti, N. Chevrier, A. Tumanov, Y.-X. Fu, N. Hacohen, and U. H. von Andrian. 2012. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 36: 415-426.
20. Mauri, C., and A. Bosma. 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30: 221-241.
21. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
22. Chen, J., M. Trounstine, F. W. Alt, F. Young, C. Kurahara, J. F. Loring, and D. Huszar. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5: 647-656.
23. Southam, D. S., M. Dolovich, P. M. O'Byrne, and M. D. Inman. 2002. Distribution of intranasal instillations in mice: effects of volume, time, body position and anesthesia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L833-L839.
24. Percopo, C. M., E. J. Dubovi, R. W. Renshaw, K. D. Dyer, J. B. Domachowske, and H. F. Rosenberg. 2011. Canine pneumovirus replicates in mouse lung tissue and elicits inflammatory pathology. Virology 416: 26-31.
25. Xie, Z., T. R. Geiger, E. N. Johnson, J. K. Nyborg, and K. M. Druey. 2008. RGS13 acts as a nuclear repressor of CREB. Mol. Cell 31: 660-670.
26. van't Wout, J. W., R. Poell, and R. van Furth. 1992. The role of BCG/PPDactivated macrophages in resistance against systemic candidiasis in mice. Scand. J. Immunol. 36: 713-719.
27. Kleinnijenhuis, J., J. Quintin, F. Preijers, L. A. B. Joosten, D. C. Ifrim, S. Saeed, C. Jacobs, J. van Loenhout, D. de Jong, H. G. Stunnenberg, et al. 2012. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA 109: 17537-17542.
28. Duggan, J. M., D. You, J. O. Cleaver, D. T. Larson, R. J. Garza, F. A. Guzman Pruneda, M. J. Tuvim, J. Zhang, B. F. Dickey, and S. E. Evans. 2011. Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J. Immunol. 186: 5916-5926.
29. Clement, C. G., S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al. 2008. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 177: 1322-1330.
30. Tuvim, M. J., S. E. Evans, C. G. Clement, B. F. Dickey, and B. E. Gilbert. 2009. Augmented lung inflammation protects against influenza A pneumonia. PLoS ONE 4: e4176.
31. Cleaver, J. O., D. You, D. R. Michaud, F. A. Guzman Pruneda, M. M. Leiva Juarez, J. Zhang, P. M. Weill, R. Adachi, L. Gong, S. J. Moghaddam, et al. 2014. Lung epithelial cells are essential effectors of inducible resistance to pneumonia. Mucosal Immunol. 7: 78-88.
32. Yeo, J. M., H. J. Lee, J. W. Kim, J. B. Lee, S. Y. Park, I. S. Choi, and C. S. Song. 2013. Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response. Int. Immunopharmacol. 18: 50-54.
33. Youn, H. N., D. H. Lee, Y. N. Lee, J. K. Park, S. S. Yuk, S. Y. Yang, H. J. Lee, S. H. Woo, H. M. Kim, J. B. Lee, et al. 2012. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res. 93: 138-143.
34. Kobayashi, N., T. Saito, T. Uematsu, K. Kishi, M. Toba, N. Kohda, and T. Suzuki. 2011. Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int. Immunopharmacol. 11: 199-203.
35. Waki, N., N. Yajima, H. Suanuma, B. M. Buddle, D. Luo, A. Heiser, and T. Zheng. 2014. Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza infection. Lett. Appl. Microbiol. 58: 87-93.
36. Goto, H., A. Sagitani, N. Ashida, S. Kato, T. Hirota, T. Shinoda, and N. Yamamoto. 2013. Anti-influenza virus effects of both live and non-live Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity. Br. J. Nutr. 110: 1810-1818.
37. Choi, Y. S., and N. Baumgarth. 2008. Dual role of B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
38. Jayasekera, J. P., E. A. Moseman, and M. C. Carroll. 2007. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 81: 3487-3494.
39. Rangel-Moreno, J., L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall. 2006. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116: 3183-3194.
40. Shi, G. X., K. Harrison, G. L. Wilson, C. Moratz, and J. H. Kehrl. 2002. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169: 2507-2515.